Heron Therapeutics (AXD2.F) Q2 2025 Earnings

6MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.05
-0.03
-0.01
0.02

Details

Expected EPS
-0.00549470115
Actual EPS
0.0088155
Surprise EPS
0.01
Surprise Percent
+260.44%

Description

Heron Therapeutics (AXD2.F) has reported earnings of 0.0088155 per share for Q2 2025.

0 Comments

Share your thoughts